ELEVEN BIOTHERAP Stock Price, News & Analysis
EBIO
Company Description
ELEVEN BIOTHERAP (Nasdaq: EBIO) is a publicly traded company.
EBIO stock has gained 100.6% over the past year.
This page provides a comprehensive overview of EBIO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+100.61%
Performance 1 year
$0.0
ELEVEN BIOTHERAP (EBIO) stock. Over the past 12 months, the stock has gained 100.6%.
Latest News
ELEVEN BIOTHERAP has 1 recent news article. View all EBIO news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months